2024 annual financial data
Bolt Biotherapeutics 2024 Operating margin
Bolt Biotherapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -949.91%.
Operating income was -73,048,000 USD and net income was -63,118,000 USD.
Operating cash flow was -61,289,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,690,000 USD
- Operating income
- -73,048,000 USD
- Net income
- -63,118,000 USD
- Operating cash flow
- -61,289,000 USD